market data recent avail data
aflac incorpor princip activ
provid supplement health life insur
servic japan also sell
medical/sick rider cancer plan live
addit cancer plan cancer life
benefit hospit outpati servic
relat cancer lump-sum benefit
upon initi diagnosi intern cancer
benefit hospit due accid
sick type supplement health
insur hospit intens care accid
disabl hospit indemn long-term care
short-term disabl dental plan
upgrad buy hold improv fundament
upgrad share buy hold upgrad share
compani base four main reason japan branch
convers complet believ earn result demonstr
pent demand afl product compani appear
final crack distribut product set
geographi event becom beat rais stori
shift product japan sector sector serv
help improv overal margin compani often comp
life insur mani way rel broader equiti market
well compani histor trade share appear attract
valu inform full report point
increas price target arriv price
target appli multipl ep estim
equat north one-year forward book valu ex-
aoci estim
maintain ep estim maintain
ep estim compar current consensu
maintain ep estim compar current
consensu
sandler neill partner right reserv sandler neill seek busi
compani cover research report result investor awar sandler neill may
conflict interest could affect object report investor consid report
singl factor make invest decis pleas see import disclosur analyst
certif appendix report
upgrad rate share buy hold also maintain ep estim
ep estim consensu current
upgrad share compani base four main reason
japan branch convers complet believ earn result demonstr
pent demand afl product
compani complet convers aflac japan branch subsidiari aflac life insur japan ltd
april shortli thereaft introduc new cancer product sale cancer product grow
sector product overal quarter
case previou year sale first half given year rather strong agent
push much back half year believ go case year reason
sector sale actual rather weak suggest pent agent
demand wait japan branch convers complet pull forward base
discuss manag appear april particularli stronger month june
could possibl indic agent simpli wait japan branch convers complet
prior submit product applic
new cancer insur product market histor take bit time agent get
educ new product new product featur partial somewhat surpris
magnitud growth sector sale new product often bleed growth sale
product compani sinc new product give agent ad reason contact client
purchas product within afl portfolio
sinc year sinc new medic product launch would surpris see
new product launch discuss analyst brief septemb tokyo
earn confer call compani note work new product product enhanc
cancer medic also protection-typ area well
last year follow agreement japan compani phase sale
cancer insur product postal outlet new cancer product first introduct
access japan outlet time reflect highest product ever japan
believ demonstr posit compani cancer product drive
sale next sever quarter
importantli appear rather strong correl movement share
price sector sale volum japan
share price sector sale volum correl
compani appear final crack distribut product set
geographi event
histor focus distribut segment product independ agent
insur broker attempt go upstream case size increasingli
better posit product insur broker distribut channel believ one day pay
certainli help posit product channel
growth broker relationship distribut product driven busi
season natur back end load given year good thing demonstr
deeper penetr relationship broker
broker tend sale given year especi last coupl week
year pretti clear lowest quarter sale expect
ramp think remain unchang
talk increas season due relationship broker find good thing
compani previous agent driven sale appear deepli penetr
broker network access larger case sale result
greater penetr brokerag channel driven sale start grow
total sale million lh
 yoygrowth sale rh
becom beat rais stori shift product japan sector sector
serv help improv overal margin
increasingli priorit sale sector benefit product de-emphasize
sector life product compani undergon chang report underwrit margin japan
segment make sens given target benefit ratio variou product
sector product larg life product act differ sector product sector product
benefit product cancer lead caus death japan natur buyer countri despit
long-term demograph trend face japan fact believ long-term demograph trend mean
short intermedi term number net increment buyer cancer product given concern
diseas popul age
advanc treatment protocol often time patient abl pursu cancer treatment outpati
basi result fewer day hospit pay-out benefit cancer product
result consist declin benefit ratio composit afl japan segment sale
migrat toward sector product away sector product product often time
higher up-front expens sector product larg higher overal profit margin
grown sector sale benefit ratio drop
compani pull back sale sector product number year outright
curtail sale product someth realli began happen earnest last coupl year
counter argument could in-forc larg focu sector sale long
grow sale sector sale long arduou slog benefit de minimi
short-term would point sector earn premium repres roughli total annual earn
premium focu grow sector sale paid dividend
furthermor believ invest commun includ somewhat behind curv
adapt earn expect new lower benefit ratio larg beat rais stori
histor magnitud earn beat increas recent year
compani often comp life insur mani way rel broader
equiti market well compani histor trade share appear attract valu
compani comp life insur coverag univers squar given mani life insur
peer also sell life insur benefit product well said afl presenc japan
annual earn premium come benefit product less interest rate sensit strong
stabl margin unlik mani life insur product frankli insur benefit product closer
property-casualti insur underwrit standpoint underwrit life insur
among highest oper roe ex-aoci profil coverag univers anticip
compani gener oper roe ex-aoci would
note life insur coverag univers median respect
consid share gener trade premium broader life insur gener hard craft
argument cheap stock share current trade book valu
ex-aoci compar peer group averag
said would note consid trade realli
longer life insur benefit insur compani track record peer averag
return profil absent volatil believ share current offer investor attract entri point look
back previous trade earn prior financi crisi averag price-to-forward earn
multipl much higher today solidli mid-teen averag max basi
